Sunshine Biopharma (SBFM) said Monday its Canadian unit Nora Pharma has launched a generic version of Everolimus in Canada.
The company said the drug is a substitute for Afinitor and is used to treat certain types of cancer, including advanced kidney cancer, certain breast cancers, and specific neuroendocrine tumors.
The product is available in 2.5 mg, 5 mg, and 10 mg tablet doses, Sunshine said.
Shares of the company were up more than 16% in recent Monday premarket activity.
Price: 1.46, Change: +0.21, Percent Change: +16.84
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。